Download PDF
Hamostaseologie 1996; 16(02): 097-106
DOI: 10.1055/s-0038-1656645
Übersichtsarbeiten/Review Articles
Schattauer GmbH

Mpl-Ligand and the Regulation of Megakaryocytopoiesis

Cellular Aspects and Regulation
Karine Cohen-Solal
1   INSERM U 362, Institut Gustave Roussy, Villejuif, France
,
Najet Debili
1   INSERM U 362, Institut Gustave Roussy, Villejuif, France
,
J.-L. Villeval
1   INSERM U 362, Institut Gustave Roussy, Villejuif, France
,
W. Vainchenker
1   INSERM U 362, Institut Gustave Roussy, Villejuif, France
,
Françoise Wendling
1   INSERM U 362, Institut Gustave Roussy, Villejuif, France
› Author Affiliations
Further Information

Publication History

Publication Date:
23 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

After 35 years of research, the physiological regulator of platelet production has been isolated and its gene cloned. This discovery originates from studies performed with the myeloproliferative leukaemia virus (MPLV), a murine retrovirus which induces an acute myeloproliferative syndrome in adult mice. MPLV carries the v-mpl oncogene in its genome. This oncogene corresponds to a truncated form of the c-mpl proto-oncogene. c-mpl encodes a cytokine receptor (Mpl-R) belonging to the hematopoietin receptor superfamily. Among the hematopoietic cell lineages, Mpl-R is preferentially expressed on late MK progenitors, megakaryocytes and platelets. The ligand for Mpl-R, called Mpl-L, thrombopoietin (TPO), megakaryocyte growth and development factor (MGDF) or megapoietin, is a gly-cosylated hormone of 322 amino acids in man which comprises two domains; the N-terminus domain shares 50% similarity with erythropoietin and is respon-sible for the biological activity; the C-terminus part is required for secretion. In vitro Mpl-L is capable of directly inducing both the proliferation of MK progenitors and the terminal maturation of megakaryocytes. MK grown in vitro in presence of Mpl-L can shed platelets. Notwithstanding its major action on megakaryocytopoiesis and thrombocytopoiesis, Mpl-L also potentiates the action of other cytokines on early hematopoietic progenitors. The plasma level of Mpl-L inversely correlates with the platelet and MK mass. However, in the two major organs (liver and kidney) which synthesize Mpl-L, there is no regulation at the transcription level of the synthesis of Mpl-L by the platelet demand, suggesting that regulation of the plasma level occurs by uptake and consumption at the level of platelets. A deregulation of Mpl-L synthesis obtained by infecting, murine hematopoietic stem cells by a retrovirus containing the coding sequence for Mpl-L induces a disease which has many common features with idiopathic myelofibrosis in man. Therefore, Mpl-L might be a very useful therapeutical cytokine to treat thrombocytopenia, but these data emphasize that chronic exposure to Mpl-L may lead to a severe disease. Thus, human clinical trials will require well controlled administration protocols.

Keywords

Megakaryocytopoiesis - platelet production - Mpl-receptor - Mpl-ligand - thrombopoietin
 

  • REFERENCES

  • 1 Bartley T, Bogenberger J, Hunt P. et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117
    CrossrefPubMedGoogle Scholar
  • 2 Berardi A, Wang A, Levine J, Lopez P, Scaden D. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104
    CrossrefPubMedGoogle Scholar
  • 3 Broudy V, Lin N, Kaushansky K. Thrombo-poietin (c-mpl Ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995; 85: 1719
    PubMedGoogle Scholar
  • 4 Chang M-S, McNinch J, Basu R. et al. Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. J Biol Chem 1995; 270: 511
    CrossrefPubMedGoogle Scholar
  • 5 Chen J, Herceg-Harjacek L, Groopman J, Grabarek J. Regulation of platelet activation in vitro by the c-Mpl ligand. Blood 1995; 86: 4054
    PubMedGoogle Scholar
  • 6 Choi E, Nichol J, Hokom M, Hornkohl A, Hunt P. Recombinant human MGDF (rhuMGDF), a ligand for c-mpl, produces functional platelets from megakaryocytes in vitro. Blood 1994; 84: 242
    PubMedGoogle Scholar
  • 7 Choi E, Nichol J, Hokom M, Hornkohl A, Hunt P.. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995; 85: 402
    PubMedGoogle Scholar
  • 8 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156
    PubMedGoogle Scholar
  • 9 De Alarcon P, Schmieder J, Gringrich RMPK. Pattern of response of megakaryocytic colony stimulating activity in the serum of patients undergoing bone marrow transplantation. Exp Hematol 1988; 16: 316
    PubMedGoogle Scholar
  • 10 Debili N, Hegyi E, Navarro S. et al. In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes. Blood 1991; 77: 2326
    PubMedGoogle Scholar
  • 11 Debili N, Issaad C, Masse J. et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 1992; 80: 3022
    PubMedGoogle Scholar
  • 12 Debili N, Wendling F, Cosman D. et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995; 85: 391
    PubMedGoogle Scholar
  • 13 Debili N, Wendling F, Katz A. et al. The Mpl-Ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995; 86: 2516
    PubMedGoogle Scholar
  • 14 Farese A, Hunt P, Boone T, MacVittie T. Recombinant human megakaryocyte growth and development factor stimulates thrombo-cytopoiesis in normal nonhuman primates. Blood 1995; 86: 54
    PubMedGoogle Scholar
  • 15 Fibbe W, Heemskerk D, Laterveer L. et al. Accelerated reconstitution of platelets and erythrocytes after syngenic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 1995; 86: 3308
    PubMedGoogle Scholar
  • 16 Foster D, Sprecher C, Grant F. et al. Human thrombopoietin: gene structure, cDNA sequence, expression and chromosomal localization. Proc Natl Acad Sci USA 1994; 91: 13023
    CrossrefPubMedGoogle Scholar
  • 17 Gewirtz A. Human megakaryocytopoiesis. Semin Hematol 1986; 23: 27
    PubMedGoogle Scholar
  • 18 Gurney A, Carver-Moore K, de Sauvage F, Moore M. Thrombocytopenia in c-mpl-defi-cient mice. Science 1994; 265: 1445
    CrossrefPubMedGoogle Scholar
  • 19 Gurney A, Kuang W-J, Xie M-H, Malloy B, Eaton D, Sauvage de F-J. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombo-poietin. Blood 1995; 85: 981
    PubMedGoogle Scholar
  • 20 Hoffman R. Regulation of megakaryocyto-poiesis. Blood 1989; 74: 1196
    PubMedGoogle Scholar
  • 21 Hoffman R, Mazur E, Bruno E, Floyd V. Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies. N Engl J Med 1981; 305: 533
    CrossrefPubMedGoogle Scholar
  • 22 Issaad C, Croisille L, Katz A, Vainchenker W, Coulombel L.. A murine stromal cell line allows the proliferation of very primitive human CD34+/CD38" progenitor cells in long-term cultures and semi-solid assays. Blood 1993; 81: 2916
    PubMedGoogle Scholar
  • 23 Kaushansky K, Broudy V, Grossmann A. et al. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 1995; 96: 1683
    CrossrefPubMedGoogle Scholar
  • 24 Kaushansky K, Broudy V, Lin N. et al. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995; 92: 3234
    CrossrefPubMedGoogle Scholar
  • 25 Kaushansky K, Lok S, Holly R. et al. Murine thrombopoietin: the ligand for c-mpl expands megakaryocyte progenitors, induces their differentiation and stimulates platelet production. Nature 1994; 369: 568
    CrossrefPubMedGoogle Scholar
  • 26 Kawakita M, Enomoto K, Katayama N, Kishimoto S, Miyake T. Thrombopoiesis and megakaryocyte colony stimulating factors in the urine of patients with idiopathic thrombocytopenic purpura. Br J Haematol 1981; 48: 609
    PubMedGoogle Scholar
  • 27 Kawakita M, Ogawa M, Goldwasser ETM. Characterization of human megakaryocyte colony stimulating factor in the urinary extracts from patients with aplastic anemia and idiopathic thrombocytopenic purpura. Blood 1983; 61: 556
    PubMedGoogle Scholar
  • 28 Kelemen E, Cserhati I, Tanos B. Demonstration and some properties of human thrombopoietin in thrombocythemic sera. Acta Haematol (Basel) 1958; 20: 350
    CrossrefPubMedGoogle Scholar
  • 29 Kobayashi M, Laver J, Kato T, Miyazaki H, Ogawa M. Recombinant human thrombopoietin (Mpl Ligand) enhances proliferation of erythroid progenitors. Blood 1995; 86: 2494
    PubMedGoogle Scholar
  • 30 Ku H, Kaushansky K, Ogawa M. Thrombopoietin, the ligand for the Mpl receptor, syn-ergises with steel factor and other early-acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 1995; 86 (Suppl. 01) 1010a
    PubMedGoogle Scholar
  • 31 Kuter D, Beeler D, Rosenberg R. The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 1994; 91: 11104
    CrossrefPubMedGoogle Scholar
  • 32 Kuter D, Rosenberg R. Appearance of a megakaryocyte growth-promoting activity, Megapoietin, during acute thrombocytopenia in the rabbit. Blood 1994; 84: 1464
    PubMedGoogle Scholar
  • 33 Kuter D, Rosenberg R. The reciprocal relationship of thrombopoietin (c-Mpl Ligand) to changes in the platelet mass during busul-fan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720
    CrossrefPubMedGoogle Scholar
  • 34 Lok S, Kaushansky K, Holly R. et al. Murine thrombopoietin: expression cloning, cDNA sequence and stimulation of platelet production in vivo. Nature 1994; 369: 565
    CrossrefPubMedGoogle Scholar
  • 35 Mazur E. Megakaryocytopoiesis and platelet production: a review. Exp Hematol 1987; 15: 340
    PubMedGoogle Scholar
  • 36 Mazur E, South K. Human megakaryocyte colony-stimulating factor in sera from aplastic dogs: Partial purification, characterization and determination of hematopoietic cell lineage specificity. Exp Hematol 1985; 13: 1164
    PubMedGoogle Scholar
  • 37 McCarty J, Sprugel K, Fox N, Sabath D, Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668
    PubMedGoogle Scholar
  • 38 McDonald T. Thrombopoietin: its biology, purification, and characterization. Exp Hematol 1988; 16: 201
    PubMedGoogle Scholar
  • 39 Methia N, Louache F, Vainchenker W, Wendling F. Oligodeoxynucleotides anti-sense to the protooncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993; 82: 1395
    PubMedGoogle Scholar
  • 40 Mignotte V, Deveaux S, Filipe A, Lemar-chandel V, Roméo P. Analysis of the thrombopoietin receptor (Mpl) promoter implicates GATA and Ets proteins in the co-regulation of megakaryocyte-specific genes. Blood 1995; 86 (Suppl. 01) 32
    PubMedGoogle Scholar
  • 41 Mignotte V, Vigon I, Boucher de Creve-coeur E, Roméo P, Lemarchandel V, Chrétien S. Structure and transcription of the human c-mpl gene (Mpl). Genomics 1994; 20: 5
    CrossrefPubMedGoogle Scholar
  • 42 Miyakawa Y, Oda A, Druker B. et al. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 1995; 86: 23
    PubMedGoogle Scholar
  • 43 Murray L, Luens K, Bruno E. et al. The effects of thrombopoietin on human hematopoietic stem cells. Blood 1995; 86 (Suppl. 01) 1009a
    PubMedGoogle Scholar
  • 44 Sauvage de F, Hass P, Spencer S. et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533
    CrossrefPubMedGoogle Scholar
  • 45 Sauvage de F, Carver-Moore K, Luoh S-M. et al Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996; 183: 651
    CrossrefPubMedGoogle Scholar
  • 46 Shivdasani R, Rosenblatt M, Zucker-Franklin D. et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 1995; 81: 695
    CrossrefPubMedGoogle Scholar
  • 47 Skoda R, Seldin D, Chiang M, Peichel C, Vogt T, Leder P. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. Embo J 1993; 12: 2645
    PubMedGoogle Scholar
  • 48 Sohma Y, Akahori H, Sebi N. et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS letters 1994; 353: 57
    CrossrefPubMedGoogle Scholar
  • 49 Souyri M, Vigon I, Penciolelli J, Heard J, Tambourin P, Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990; 63: 1137
    CrossrefPubMedGoogle Scholar
  • 50 Straneva J, Yang H, Hui S, Bruno E, Hoffman R. Effects of megakaryocyte colony-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes. Exp Hematol 1987; 15: 657
    PubMedGoogle Scholar
  • 51 Straneva JE, Goheen M, Hiu S, Bruno E, Hoffman R. Terminal cytoplasmic maturation of human megakaryocytes in vitro. Exp Hematol 1986; 14: 919
    PubMedGoogle Scholar
  • 52 Vainchenker W, Kieffer N. Human megakaryocytopoiesis: In vitro regulation and characterization of megakaryocytic precursor cells by differentiation markers. Blood Rev 1988; 2: 102
    CrossrefPubMedGoogle Scholar
  • 53 Vigon I, Florindo C, Fichelson S. et al. Characterization of the murine Mpl protooncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene 1993; 8: 2607
    PubMedGoogle Scholar
  • 54 Vigon I, Mornon J, Cocault L. et al. Molecular cloning and characterization of Mpl, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992; 89: 5640
    CrossrefPubMedGoogle Scholar
  • 55 Wendling F, Maraskovsky E, Debili N. et al. The Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994; 369: 571
    CrossrefPubMedGoogle Scholar
  • 56 Wendling F, Varlet P, Charon P, Tambourin P. A retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology 1986; 149: 242
    CrossrefPubMedGoogle Scholar
  • 57 Yan X-Q, Lacey D, Fletchner F. et al. Chronic exposure to retroviral vector encoded MGDF (mpl-Ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 1995; 86: 4025
    PubMedGoogle Scholar
  • 58 Zeigler F, Sauvage de F, Widmer H. et al. In vitro megakaryocytopoietic and thrombo-poietic activity of c-mpl Ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994; 84: 4045
    PubMedGoogle Scholar